Literature DB >> 1630456

Two species of human CRK cDNA encode proteins with distinct biological activities.

M Matsuda1, S Tanaka, S Nagata, A Kojima, T Kurata, M Shibuya.   

Abstract

Two distinct human CRK cDNAs, designated CRK-I and CRK-II, were isolated from human embryonic lung cells by polymerase chain reaction and by screening of a human placenta cDNA library, respectively. CRK-I differed from CRK-II in that it lacked a 170-nucleotide sequence, suggesting that CRK-I and CRK-II were the products of alternative splicing. The amino acid sequences deduced from these two cDNAs differed in the carboxyl termini and contained one SH2 and either one or two SH3 domains. RNAse protection analysis demonstrated both CRK-I and CRK-II mRNAs in various human cells. Three CRK proteins, of 42, 40, and 28 kDa, were identified in human embryonic lung cells by means of antibodies against the SH2 region and the SH3 region of the bacterially expressed CRK-I protein. Transient expression of CRK-I and CRK-II cDNAs in COS7 cells showed that the former encoded the 28-kDa protein and the latter encoded the 40- and 42-kDa proteins. All human cell lines so far examined expressed the 40-kDa protein; however, expression of the 28- and the 42-kDa proteins was variable. In a comparison of the biological activity of the two human CRK proteins, both proteins were stably expressed in rat 3Y1 cells. All cell lines expressing CRK-I protein showed altered morphology, proliferated in soft agar, and grew as massive tumors in nude mice. Although CRK-II-expressing cells showed a slight morphologic change, they did not make colonies in soft agar or grow in nude mice. These results demonstrate that the two species of human CRK cDNA encode proteins which differ in their biological activities.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1630456      PMCID: PMC364597          DOI: 10.1128/mcb.12.8.3482-3489.1992

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  39 in total

1.  Biological and biochemical activity of v-Crk chimeras containing the SH2/SH3 regions of phosphatidylinositol-specific phospholipase C-gamma and Src.

Authors:  M Matsuda; C T Reichman; H Hanafusa
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

2.  Rat cell line 3y1 and its virogenic polyoma- and sv40- transformed derivatives.

Authors:  G Kimura; A Itagaki; J Summers
Journal:  Int J Cancer       Date:  1975-04-15       Impact factor: 7.396

3.  cDNA cloning of a novel 85 kd protein that has SH2 domains and regulates binding of PI3-kinase to the PDGF beta-receptor.

Authors:  J A Escobedo; S Navankasattusas; W M Kavanaugh; D Milfay; V A Fried; L T Williams
Journal:  Cell       Date:  1991-04-05       Impact factor: 41.582

4.  A catalogue of splice junction sequences.

Authors:  S M Mount
Journal:  Nucleic Acids Res       Date:  1982-01-22       Impact factor: 16.971

5.  Establishment and characterization of a human neuroblastoma cell line in tissue culture.

Authors:  M Sekiguchi; T Oota; K Sakakibara; N Inui; G Fujii
Journal:  Jpn J Exp Med       Date:  1979-02

6.  Characterization of two 85 kd proteins that associate with receptor tyrosine kinases, middle-T/pp60c-src complexes, and PI3-kinase.

Authors:  M Otsu; I Hiles; I Gout; M J Fry; F Ruiz-Larrea; G Panayotou; A Thompson; R Dhand; J Hsuan; N Totty
Journal:  Cell       Date:  1991-04-05       Impact factor: 41.582

7.  Identification of domains of the v-crk oncogene product sufficient for association with phosphotyrosine-containing proteins.

Authors:  M Matsuda; B J Mayer; H Hanafusa
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

8.  SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins.

Authors:  C A Koch; D Anderson; M F Moran; C Ellis; T Pawson
Journal:  Science       Date:  1991-05-03       Impact factor: 47.728

9.  Cloning of PI3 kinase-associated p85 utilizing a novel method for expression/cloning of target proteins for receptor tyrosine kinases.

Authors:  E Y Skolnik; B Margolis; M Mohammadi; E Lowenstein; R Fischer; A Drepps; A Ullrich; J Schlessinger
Journal:  Cell       Date:  1991-04-05       Impact factor: 41.582

10.  Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.

Authors:  M Popovic; M G Sarngadharan; E Read; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

View more
  87 in total

1.  v-Crk activates the phosphoinositide 3-kinase/AKT pathway in transformation.

Authors:  T Akagi; T Shishido; K Murata; H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

2.  Apoptotic regulation by the Crk adapter protein mediated by interactions with Wee1 and Crm1/exportin.

Authors:  Jesse J Smith; D Ashley Richardson; Jan Kopf; Minoru Yoshida; Robert E Hollingsworth; Sally Kornbluth
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

3.  Adaptor protein Crk is required for ephrin-B1-induced membrane ruffling and focal complex assembly of human aortic endothelial cells.

Authors:  Ken-Ichiro Nagashima; Akira Endo; Hisakazu Ogita; Akiko Kawana; Akiko Yamagishi; Akira Kitabatake; Michiyuki Matsuda; Naoki Mochizuki
Journal:  Mol Biol Cell       Date:  2002-12       Impact factor: 4.138

4.  Optimal Drift Correction for Superresolution Localization Microscopy with Bayesian Inference.

Authors:  Ahmed Elmokadem; Ji Yu
Journal:  Biophys J       Date:  2015-11-03       Impact factor: 4.033

5.  Structural requirements for function of the Crkl adapter protein in fibroblasts and hematopoietic cells.

Authors:  K Senechal; C Heaney; B Druker; C L Sawyers
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

6.  CRK protein binds to two guanine nucleotide-releasing proteins for the Ras family and modulates nerve growth factor-induced activation of Ras in PC12 cells.

Authors:  M Matsuda; Y Hashimoto; K Muroya; H Hasegawa; T Kurata; S Tanaka; S Nakamura; S Hattori
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

7.  CrkII transgene induces atypical mammary gland development and tumorigenesis.

Authors:  Kelly E Fathers; Sonia Rodrigues; Dongmei Zuo; Indrani Vasudeva Murthy; Michael Hallett; Robert Cardiff; Morag Park
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

8.  Roles for crk in cancer metastasis and invasion.

Authors:  Masumi Tsuda; Shinya Tanaka
Journal:  Genes Cancer       Date:  2012-05

9.  Models of crk adaptor proteins in cancer.

Authors:  Emily S Bell; Morag Park
Journal:  Genes Cancer       Date:  2012-05

10.  Inhibition of human immunodeficiency virus type 1 virion entry by dominant-negative Hck.

Authors:  K Tokunaga; E Kiyokawa; M Nakaya; N Otsuka; A Kojima; T Kurata; M Matsuda
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.